Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical features
OBJECTIVE: To determine the association of differential clinical features of pulmonary TB with the RDRio M. tuberculosis etiology.
METHODS: Culture-proven pulmonary TB patients (n = 272) were clinically evaluated, including history, physical examination, chest X-ray and anti-human immunodeficiency virus serology. Isolates were classified as RDRio or non-RDRio M. tuberculosis by multiplex polymerase chain reaction and further spoligotyped. Clinical and M. tuberculosis genotype data were analyzed.
RESULTS: RDRio M. tuberculosis caused disease in 26.5% (72/270) of all TB cases. The LAM genotype, of which RDRio strains are members, was responsible for 46.0% of the TB cases. Demographic data, major signs and symptoms, radiographic presentation, microbiological features and clinical outcomes were not significantly different among patients with TB caused by RDRio and non-RDRio strains.
CONCLUSIONS: Disease caused by M. tuberculosis RDRio strains was not clinically distinctive or more severe than disease caused by non-RDRio strains in this series of TB patients. Larger prospective studies specifically designed to disclose differential clinical characteristics of TB caused by specific M. tuberculosis lineages are needed.
Keywords: Mycobacterium tuberculosis; RDRio; clinical features; epidemiology; lineage
Document Type: Research Article
Affiliations: 1: Multidisciplinary Research Laboratory, Clementino Fraga Filho University Hospital, Institute of Thoracic Diseases, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil 2: Laboratory of Applied Molecular Biology to Mycobacteria, Oswaldo Cruz Institute, Rio de Janeiro, Rio de Janeiro, Brazil 3: Tuberculosis Control Program, Clementino Fraga Filho University Hospital, Institute of Thoracic Diseases, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil 4: Mycobacteriology Laboratory, Instituto de Microbiologia, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil 5: Tuberculosis Academic Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil 6: Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York, New York, USA; and Centers for Disease Control in Haiti, Dulles, Virginia, USA
Publication date: 01 October 2012
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content